2015-11-16 20:26:15 UTC

Current Role of FMT for Treatment of C. Difficile

Duration

25 minutes

Takeaways

Christina M. Surawicz, MD, MACG, discusses the efficacy of fecal microbiota transplantation to treat C. difficile, IBD and other GI disorders.

Presented at Digestive Disease Week®, May 16-19, 2015, Walter E. Washington Convention Center, Washington, DC

About the Instructors

Dr. Christina M. Surawicz, MD, MACG
Professor of Medicine, Division of Gastroenterology
University of Washington School of Medicine

This is only a preview. Full access is reserved for AGA members. Login or learn more about becoming a member.

Login

More on Fecal microbiota transplant

Join Us for the Clinician’s Guide to Fecal Microbiota Transplant (FMT) Workshop

Aug. 1, 2017

Workshop will take place on Jan. 18, 2018, just prior to the new Crohn’s and Colitis Congress™ in Las Vegas, NV.

A Selection of the Best AGA Abstracts of DDW® 2017

July 27, 2017

Read the best AGA abstracts from Digestive Disease Week, published in Gastro.

Study Finds C. Diff Infections on the Rise, FMT Most Promising Treatment

July 5, 2017

AGA is tracking outcomes of fecal microbiota transplantation through an observational registry.